Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2008
12/17/2008CN101322727A Exterior patch for freeing collateral vessels and dispelling pain and producing method thereof
12/17/2008CN101322715A Anti-coxsackie medicament composition and medicine use thereof
12/17/2008CN101322713A Applications of gastrodine in preparing cysteine proteinase-3 active inhibitor
12/17/2008CN101322706A Applications of hexa-gelsemicine in preparing medicament for treating chronic ache
12/17/2008CN101322705A Applications of koumine in preparing medicament for treating chronic ache
12/17/2008CN101322704A Applications of gelsemine in preparing medicament for treating chronic ache
12/17/2008CN101322695A Piclofenac potassium sustained release capsule and preparing technique thereof
12/17/2008CN101322694A Piclofenac potassium sustained release tablets and preparing technique thereof
12/17/2008CN100443501C Mitochondria traffic protein molecule for human marrow stromal cell and sequence encoding same and use thereof
12/17/2008CN100443498C Use of anti-inflammatory medicine for scheelite total saponin and its saponin compound
12/17/2008CN100443477C Substituted benzoxazoles and analogues as estrogenic agents
12/17/2008CN100443105C A medicine for treating rheumatoid arthritis and hyperosteogeny and preparation method thereof
12/17/2008CN100443091C Anti-inflammation medicine
12/16/2008US7465803 Nitroderivatives as drugs for diseases having an inflammatory basis
12/16/2008US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases
12/16/2008US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
12/16/2008US7465718 Ansamycins having improved pharmacological and biological properties
12/16/2008US7465548 associated with the disorders of the peripheral and central nervous system, cardiovascular diseases, hematological diseases, cancer, inflammation, urological diseases, respiratory diseases and gastroenterological diseases
12/16/2008US7465445 Methods of preventing or treating graft versus host reaction by administering an antibody or portion thereof that binds to AILIM
12/16/2008US7465444 Methods of suppressing or treating an inflammatory bowel disease by administering an antibody or portion thereof that binds to AILIM
12/16/2008US7465437 Delivery of anti-migraine compounds through an inhalation route
12/16/2008US7465436 Aerosol for delivery of benzotropine, pergolide, amantadine, deprenyl, or ropinerole, formed by vaporizing the drug that is coated on a solid support and condensing the vapor to form particles containing least 10 % by weight of the drug and less than 5 % by weight of degradation products
12/16/2008US7465435 Delivery of beta-blockers through an inhalation route
12/16/2008CA2133885C Crystalline inclusion complex of diclofenac with beta-cyclodextrin
12/11/2008WO2008151211A1 Substituted benzoylamino-indan-2-carboxylic acids and related compounds
12/11/2008WO2008150231A1 New heterocyclic compounds for treatment of respiratory, airway or inflammatory disorders
12/11/2008WO2008149834A1 Pyrimidodiazepinone derivative
12/11/2008WO2008149688A1 Composition having antioxidative activity
12/11/2008WO2008149428A1 Therapeutic agent and preventive agent for autoimmune disease, inflammation and nerve disease
12/11/2008WO2008149354A2 Agents for the treatment of inflammatory diseases and methods of using same
12/11/2008WO2008149181A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
12/11/2008WO2008149177A2 Marine lipid compositions and uses thereof
12/11/2008WO2008149168A1 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands
12/11/2008WO2008149110A1 Bicyclor [2.2.1] hept-7-ylamine derivatives and their use in the treatment of diseases and conditions in which m3 muscarinic receptor activity and beta-adrenergic activity are implicated
12/11/2008WO2008130953A3 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands
12/11/2008WO2008119825A3 Imidazolidine carboxamide derivatives as p2x7 modulators
12/11/2008WO2008113863A3 Nitrosated derivatives of 2,5-dihydroxybenzene compounds
12/11/2008WO2008109368A3 Nucleic acid compounds for inhibiting vegfr gene expression and uses thereof
12/11/2008WO2008100621A3 Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s
12/11/2008WO2008093302A3 Method for decreasing inflammation and oxidative stress in mammals
12/11/2008WO2008063603A3 Methods, compositions, and kits for treating pain and pruritis
12/11/2008WO2008008374A3 Ccr2 inhibitors and methods of use thereof
12/11/2008US20080306262 5-[[(2,3-Difluorophenyl)methyl]thio]-7-[[2-hydroxy-1-(hydroxymethyl) 1 methylethyl]amino]-thiazolo[4,5-d]pyrimidin-2(3H)-one; asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis
12/11/2008US20080306162 Treatment of Inflammatory Disorders and Pain
12/11/2008US20080306146 Dosing Regimens for Cox-2 Inhibitor
12/11/2008US20080306140 Isoflavonoid Dimers
12/11/2008US20080306130 Inhibitors of ubiquitin E1
12/11/2008US20080306129 Benzimidazoles useful as modulators of ion channels
12/11/2008US20080306123 Novel compounds
12/11/2008US20080306117 Ep4 receptor antagonists
12/11/2008US20080306113 Methods for treating macular degeneration using 4-(amino)-2-(2,6-dioxo(3-piperidyle))-isoindoline-1,3-dione
12/11/2008US20080306110 Alkylnitrile Quinolines as Nk-3 Receptor Ligands
12/11/2008US20080306107 Compounds
12/11/2008US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
12/11/2008US20080306082 [4-(Benzo[B]Thiophen-2-Yl) Pyrimidin-2-Yl]-Amine Derivatives As Ikk-Beta Inhibitors For The Treatment Of Cancer And Inflammatory Diseases
12/11/2008US20080306068 Suppression cytokines, tumor necrosis factor
12/11/2008US20080306065 Metalloproteinase Inhibitors
12/11/2008US20080306037 Product for Use in the Prevention and Treatment of Cardiovascular Diseases, Cancer and Chronic Inflammatory Diseases
12/11/2008US20080306029 Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
12/11/2008US20080305996 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
12/11/2008US20080305190 Salvia hispanica I (Chia) in the management and treatment of cardiovascular disease, diabetes and associated risk factors
12/11/2008US20080305187 Use of Parathyroid Hormone for Treating Periodontal Disease and for Other Dental Applications
12/11/2008US20080305176 Process For Loading Polymer Particles With Drug
12/11/2008US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof
12/11/2008US20080305090 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times
12/11/2008US20080305089 Pharmaceutical Composition for Protection from Allergies and Inflammatory Disorders
12/11/2008US20080305078 Soluble Il-17Rc Variant and Uses Thereof
12/11/2008CA2691446A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
12/11/2008CA2690001A1 Substituted benzoylamino-indan-2-carboxylic acids and related compounds
12/11/2008CA2689612A1 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands
12/11/2008CA2689374A1 Pyrimidodiazepinone derivative
12/10/2008EP2000469A2 Acylaminopiperidine compound
12/10/2008EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
12/10/2008EP2000144A1 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono-and disaccharide-based compounds
12/10/2008EP2000143A2 Transdermal gel compositions containing testosterone and their use for the treatment of fibromyalgia, chronic fatigue syndrome, muscle pain or decreased libido
12/10/2008EP2000136A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/10/2008EP1999135A2 Kinase inhibitors
12/10/2008EP1999132A1 Azolopyrimidines as inhibitors of cannabinoid 1 activity
12/10/2008EP1999130A1 Pyridopyrimidine derivatives and their use as pde4 inhibitors
12/10/2008EP1999111A2 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
12/10/2008EP1999107A2 Amine derivatives
12/10/2008EP1998781A2 Treatment of pain
12/10/2008EP1998779A2 Use of (3s)-n-hydroxy-4-({4-ý(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide or (s)-n-hydroxy-4-(4-but-2-ynyloxy-benzenesulfonyl) -2,2-dimethyl-thiomorpholine -3-carboxamide for treating inflammatory skin pathologies
12/10/2008EP1735312B1 Substituted diaza-spiro-[5.5 -undecane derivatives and their use as neurokinin antagonists
12/10/2008EP1613300B1 Photostabilized topical formulations of ketoprofen containing two uv filters
12/10/2008EP1601663B1 Nitrate esters of phenylaminothiophenacetic acid derivatives
12/10/2008EP1511730B1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/10/2008EP1403284B1 HAb18G/CD147, ITS ANTAGONIST AND APPLICATION
12/10/2008EP1396487B1 Phenylpyridine carbonyl piperazine derivative
12/10/2008EP1391199B1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
12/10/2008EP1379222B1 Orodispersible effervescent tablets
12/10/2008EP1274450B1 Medical uses of agonsist and antagonists of IL-174
12/10/2008EP1252893B1 Medicine containing anemonin as effective component for treating aseptic inflammation
12/10/2008EP1249160B1 Model animal with favorite onset of rheumatoid arthritis
12/10/2008EP1042350B1 Inducible phosphofructokinase and the warburg effect
12/10/2008EP1002069B1 Peptides containing the motif igd and their use as cell migration modulators
12/10/2008CN101321765A Chromone derivatives useful as antagonists of VR1 receptors
12/10/2008CN101321758A Novel 5,6-dihydropyrazolo[3,4-e] [l,4]diazepin-4 (ih) -one derivatives for the treatment of asthma and chronic obstructive pulmonary disease
12/10/2008CN101321749A Novel vinylogous acids derivatives
12/10/2008CN101321745A Nitrogen-containing heterocyclic compound and pharmaceutical application thereof